|2.90||-0.06 / -2.03%|
As of 3:59pm ET
|2.90||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +124.14% increase from the last price of 2.90.
The current consensus among 3 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.